These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22294517)

  • 1. Simple baseline correction for 1H MRSI data of the prostate.
    Wright AJ; Heerschap A
    Magn Reson Med; 2012 Dec; 68(6):1724-30. PubMed ID: 22294517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.
    Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P
    Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J; Vogel M; Gross P; Heuck A
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
    Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
    Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer in magnetic resonance imaging: diagnostic utilities of spectroscopic sequences.
    Caivano R; Cirillo P; Balestra A; Lotumolo A; Fortunato G; Macarini L; Zandolino A; Vita G; Cammarota A
    J Med Imaging Radiat Oncol; 2012 Dec; 56(6):606-16. PubMed ID: 23210579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
    Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S
    NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
    Wright AJ; Buydens LM; Heerschap A
    NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic conformal prescription of very selective saturation bands for in vivo 1H-MRSI of the prostate.
    Venugopal N; McCurdy B; Hovdebo J; Al Mehairi S; Alamri A; Sandhu GS; Sivalingam S; Drachenberg D; Ryner L
    NMR Biomed; 2012 Apr; 25(4):643-53. PubMed ID: 22162346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short echo time in vivo prostate ¹H-MRSI.
    Venugopal N; McCurdy B; Al Mehairi S; Alamri A; Sandhu GS; Sivalingam S; Drachenberg D; Ryner L
    Magn Reson Imaging; 2012 Feb; 30(2):195-204. PubMed ID: 22154684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
    Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Note: evaluation of the uncertainties in (choline + creatine)/citrate ratios measured by proton MR spectroscopic imaging in patients suspicious for prostate cancer.
    Zbýň Š; Krššák M; Memarsadeghi M; Gholami B; Haitel A; Weber M; Helbich TH; Trattnig S; Moser E; Gruber S
    Rofo; 2014 Jul; 186(7):698-702. PubMed ID: 24940925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.
    Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW
    NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
    Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
    NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
    Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
    Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI of the prostate: clinical relevance and emerging applications.
    Mazaheri Y; Shukla-Dave A; Muellner A; Hricak H
    J Magn Reson Imaging; 2011 Feb; 33(2):258-74. PubMed ID: 21274967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
    Near J; Romagnoli C; Bartha R
    Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.